Want to see IN:FISCHER full AI Analyst Report?
FISCHER Stock Chart & Stats
₹43.67
--
Market closed
₹43.67
--
Day’s Range― - ―
52-Week Range₹31.13 - ₹124.20
Previous CloseN/A
VolumeN/A
Average Volume (3M)267.56K
Market Cap
₹25.49B
Enterprise Value₹23.33B
Total Cash (Recent Filing)₹428.70M
Total Debt (Recent Filing)₹370.08M
Price to Earnings (P/E)95.0
Beta0.26
Next Earnings
Aug 06, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield0.01%
Share Statistics
EPS (TTM)0.22
Shares Outstanding648,515,440
10 Day Avg. Volume611,655
30 Day Avg. Volume267,556
Financial Highlights & Ratios
PEG Ratio0.01
Price to Book (P/B)6.83
Price to Sales (P/S)8.52
P/FCF Ratio-20.39
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Revenue And Margin ExpansionFY2026 shows a clear step-change: material revenue scale and double-digit operating profitability. Durable higher margins at larger scale improve coverage of fixed costs, support reinvestment in R&D and distribution, and materially strengthen the firm's ability to sustain growth over quarters.
Rapid Top-line And EPS GrowthVery strong revenue and EPS growth metrics indicate accelerating product adoption and operating leverage. Sustained high organic growth increases optionality to expand market share, justify capacity buildout, and improve long-term margin sustainability if trends continue.
Improving Balance-sheet MetricsEquity expansion and a moderate D/E in the latest year reduce solvency strain and enhance financing flexibility. A stronger capital base improves ability to fund product development and absorb shocks, supporting medium-term execution and strategic initiatives.
Bears Say
Persistent Negative Operating And Free Cash FlowDespite accounting profits, sustained deep cash burn suggests working-capital strain, heavy reinvestment needs, or collection timing issues. Ongoing negative FCF increases dependency on external funding and creates sustainability risk if cash generation doesn't normalize.
Material Rise In Debt Versus FY2024A large jump in borrowings elevates refinancing and interest-rate exposure. Even with recent manageable leverage ratios, the rapid increase in debt heightens execution risk and limits free cash flow flexibility, especially if operational cash conversion stalls.
Historical Earnings And Equity VolatilityPrior years of losses and negative equity indicate the business model and execution have been unstable. Such legacy volatility raises doubt about the durability of recent improvements and implies higher operational and governance risk until multi-year consistency is demonstrated.
Fischer Medical Ventures Ltd News
FISCHER FAQ
What was Fischer Medical Ventures Ltd’s price range in the past 12 months?
Fischer Medical Ventures Ltd lowest stock price was ₹31.13 and its highest was ₹124.20 in the past 12 months.
What is Fischer Medical Ventures Ltd’s market cap?
Fischer Medical Ventures Ltd’s market cap is ₹25.49B.
When is Fischer Medical Ventures Ltd’s upcoming earnings report date?
Fischer Medical Ventures Ltd’s upcoming earnings report date is Aug 06, 2026 which is in 32 days.
How were Fischer Medical Ventures Ltd’s earnings last quarter?
Fischer Medical Ventures Ltd released its earnings results on May 29, 2026. The company reported -₹0.11 earnings per share for the quarter, missing the consensus estimate of N/A by -₹0.11.
Is Fischer Medical Ventures Ltd overvalued?
According to Wall Street analysts Fischer Medical Ventures Ltd’s price is currently Overvalued.
Does Fischer Medical Ventures Ltd pay dividends?
Fischer Medical Ventures Ltd pays a Notavailable dividend of ₹0.005 which represents an annual dividend yield of 0.01%. See more information on Fischer Medical Ventures Ltd dividends here
What is Fischer Medical Ventures Ltd’s EPS estimate?
Fischer Medical Ventures Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Fischer Medical Ventures Ltd have?
Fischer Medical Ventures Ltd has 648,515,440 shares outstanding.
What happened to Fischer Medical Ventures Ltd’s price movement after its last earnings report?
Fischer Medical Ventures Ltd reported an EPS of -₹0.11 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 1.627%.
Which hedge fund is a major shareholder of Fischer Medical Ventures Ltd?
Currently, no hedge funds are holding shares in IN:FISCHER
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Fischer Medical Ventures Ltd
Fischer Medical Ventures Limited, established in 1993 and headquartered in Chennai, India, is a global provider of medical equipment. The company's operations encompass the manufacturing, distribution, leasing, and maintenance of a wide array of medical devices. Its comprehensive product offerings include advanced diagnostic imaging systems such as MRI and CT scanners; specialized screening tools for cancer and tuberculosis, including handheld x-ray units; and innovative solutions like spincare technology and contactless screening. The portfolio further extends to preventive health kiosks, e-health access points, various software solutions, plant-derived nutraceuticals, mental health solutions, and a range of other preventive diagnostic devices and ancillary medical instruments. The company adopted its current name, Fischer Medical Ventures Limited, in March 2024, having previously operated as Fischer Chemic Limited.
Technical Analysis
Aarti Pharmalabs Limited
―
Marksans Pharma Limited
―
Shilpa Medicare Limited
―
Strides Pharma Science Ltd
―
Thyrocare Technologies Ltd
―